Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 252

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma

Open access
Breiteneder, Heimo, Peng, Ya‐Qi, Agache, Ioana, Diamant, Zuzana, Eiwegger, Thomas, Fokkens, Wytske J., Traidl‐Hoffmann, Claudia, Nadeau, Kari, O'Hehir, Robyn E., O'Mahony, Liam, Pfaar, Oliver, Torres, Maria J., Wang, De‐Yun, Zhang, Luo, Akdis, Cezmi A.·2020·Allergy

Abstract

Modern health care requires a proactive and individualized response to diseases, combining precision diagnosis and personalized treatment. Accordingly, the approach to patients with allergic diseases encompasses novel developments in the area of personalized medicine, disease phenotyping and endotyping, and the development and application of reliable biomarkers. A detailed clinical history and physical examination followed by the detection of IgE immunoreactivity against specific allergens still represents the state of the art. However, nowadays, further emphasis focuses on the optimization of diagnostic and therapeutic standards and a large number of studies have been investigating the biomarkers of allergic diseases, including asthma, atopic dermatitis, allergic rhinitis, food allergy, urticaria and anaphylaxis. Various biomarkers have been developed by omics technologies, some of which lead to a better classification of distinct phenotypes or endotypes. The introduction of biologicals to clinical practice increases the need for biomarkers for patient selection, prediction of outcomes and monitoring, to allow for an adequate choice of the duration of these costly and long‐lasting therapies. Escalating healthcare costs together with questions about the efficacy of the current management of allergic diseases require further development of a biomarker‐driven approach. Here, we review biomarkers in diagnosis and treatment of asthma, atopic dermatitis, allergic rhinitis, viral infections, chronic rhinosinusitis, food allergy, drug hypersensitivity and allergen immunotherapy with a special emphasis on specific IgE, the microbiome and the epithelial barrier. In addition, EAACI guidelines on biologicals are discussed within the perspective of biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.14582

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 20 references

Cited by

See all 252

Metadata

Authors
Breiteneder, H., Peng, Y., Agache, I., Diamant, Z., Eiwegger, T., Fokkens, W. J., Traidl‐Hoffmann, C., Nadeau, K., O'Hehir, R. E., O'Mahony, L., Pfaar, O., Torres, M. J., Wang, D., Zhang, L., & Akdis, C. A.
Venue
Allergy
Publisher
Wiley
Published
2020-09-30
Volume
75
Issue
12
Pages
3039-3068
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W3084176537
Cited by
252
References
20
FWCI
17.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. https://app.cochat.ai/papers/10.1111/all.14582
The paper
Breiteneder, H., Peng, Y., Agache, I., Diamant, Z., Eiwegger, T., Fokkens, W. J., Traidl‐Hoffmann, C., Nadeau, K., O'Hehir, R. E., O'Mahony, L., Pfaar, O., Torres, M. J., Wang, D., Zhang, L., & Akdis, C. A. (2020). Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy. https://doi.org/10.1111/all.14582

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.